gemcitabine-ibandronate conjugate (MBC Pharma)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namegemcitabine-ibandronate conjugate (MBC Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell cycle inhibitorsOsteoclasts inhibitorsBone resorption inhibitors
TargetsUpdating
Therapy Area/IndicationsOsteosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMbc Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesMbc Pharma Inc
Inactive CompaniesN/A
Active IndicationsOsteosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A